CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare
Diabetic Foot Ulcer Patients Continue to Benefit from Sustainable Fish-Skin Technology Arlington, VA and Reykjavik,
Diabetic Foot Ulcer Patients Continue to Benefit from Sustainable Fish-Skin Technology Arlington, VA and Reykjavik,
Kerecis is presenting the findings of the Odinn study at SAWC, currently happening in Las
John C Lantis II, MD, Chairman Kerecis Scientific Advisory Board © Kerecis Attendees are learning
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.
© 2010-2024 Kerecis. All Rights Reserved